The molecular mechanism was associated with PAFAH1B3, which resulted to be inactive and hence, without capacity of interacting with LIS1 (related to lissencephaly), a member of the heterotrimeric G protein complex PAF-AH1B. This evidence concerns the gene PAFAH1B3 and lissencephaly spectrum disorders.